A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
Clinical trial NCT02377466 · TERMINATED
Trial details
- NCT number
- NCT02377466
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-07-24
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.